MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to catheter...
-$3,041K
Net loss
attributable to catheter...
-$1,681K
(58.44%↑ Y/Y)
Deemed dividend on
warrant inducement...
$1,360K
Less net gain
attributable to...
-$9K
Europe
$154K
(1825.00%↑ Y/Y)
US
$94K
Net loss
-$1,690K
(58.22%↑ Y/Y)
Income tax benefit
-$175K
(75.83%↑ Y/Y)
Change in fair value of
deferred consideration
$2,877K
Product
$248K
Service
$184K
Interest income
$2K
(-88.89%↓ Y/Y)
Loss from operations
before income tax...
-$1,865K
(60.89%↑ Y/Y)
Total other income
(expense), net
$453K
(137.94%↑ Y/Y)
Revenues
$432K
(202.10%↑ Y/Y)
Change in fair value of
minority equity interest
-$2,302K
Interest
expense-Nonrelated Party
$76K
Interest
expense-Related Party
$43K
Other expenses, net
-$5K
Operating loss
-$2,318K
(35.16%↑ Y/Y)
Gross profit
$390K
(195.45%↑ Y/Y)
Total cost of revenues
$42K
(281.82%↑ Y/Y)
Total operating
expenses
$2,708K
(-26.95%↓ Y/Y)
Product
$31K
Service
$11K
Selling, general and
administrative
$2,559K
(-26.57%↓ Y/Y)
Research and development
$149K
(44.66%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Catheter Precision, Inc. (VTAK)
Catheter Precision, Inc. (VTAK)